ledipasvir
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of adult patients with chronic hepatitis C (CHC).
Form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
Manufacturer: Strides Pharma Science Limited
-
The drug is intended for the treatment of chronic hepatitis C in adults and children aged 12 to 18 years.
Form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
Manufacturer: Hetero Labs Limited
-
It is indicated for the treatment of adult patients with chronic hepatitis C (CHC).
Form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
Manufacturer: Strides Pharma Science Limited